V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310010774 | 310005353 | 1.96 | 0 | Curative (C) | null | 2015-01-16 | Cetuximab + Radiotherapy Load | 02 | N | 310025420 | ALEMTUZUMAB |
| 310010775 | 310005356 | 1.62 | 95.7 | Disease modification (D) | 2015-02-28 | 2015-03-05 | NIVOLUMAB | null | null | 310025484 | RUXOLITINIB |
| 310010776 | 310005361 | 1.69 | 50 | Curative (C) | 2014-09-24 | 2015-01-12 | MITOMYCIN | N | null | 310025578 | MPV |
| 310010777 | 310005363 | 1.6 | 67 | Palliative (P) | 2016-11-30 | 2016-11-30 | Carboplatin + Docetaxel | N | N | 310025608 | OXALIPLATIN + MDG |
| 310010778 | 310005378 | null | 111.2 | Palliative (P) | 2016-02-16 | 2016-02-02 | Doxorubin 50mg/m2 | 02 | N | 310025687 | CETUXIMAB + CISPLATIN + FU |
| 310010779 | 310005380 | 1.78 | 79.3 | Not known (9) | 2017-12-01 | 2018-04-08 | Thalidomide 100mg | null | null | 310025703 | CAPECITABINE + OXALIPLATIN |
| 310010780 | 310005382 | 1.57 | null | Curative (C) | 2015-11-06 | 2015-12-02 | Oxaliplatin + Modified de Gramont | N | N | 310025710 | PEG INTERFERON |
| 310010781 | 310005390 | 1.81 | null | Palliative (P) | 2014-12-02 | 2015-03-27 | R IVAC | N | N | 310025719 | GEMCITABINE + OXALIPLATIN |
| 310010783 | 310005398 | 1.64 | 104 | Palliative (P) | 2016-04-05 | 2016-04-05 | Lenalidomide Cycle 26 onwards (PAS) | N | N | 310025753 | DOXORUBICIN |
| 310010784 | 310005399 | 1.57 | 81 | Curative (C) | 2018-05-13 | 2018-05-17 | Hydroxycarbamide | 02 | N | 310000138 | CISPLATIN + ETOPOSIDE |
| 310010785 | 310005402 | 1.79 | 64.5 | Curative (C) | 2015-09-26 | 2015-09-26 | IPILIMUMAB + NIVOLUMAB | N | N | 310000297 | TRABECTEDIN |
| 310010786 | 310008379 | 1.62 | 0 | Curative (C) | 2018-10-28 | 2019-02-19 | Enzalutamide | N | N | 310000433 | CYTARABINE + METHOTREXATE |
| 310010787 | 310005408 | 1.4 | 85.7 | Palliative (P) | 2017-12-13 | 2017-12-13 | GEMCITABINE + TREOSULPHAN | N | N | 310000469 | CAPECITABINE |
| 310010788 | 310008384 | 1.83 | 92.2 | Curative (C) | 2017-05-06 | 2017-05-18 | Methotrexate + Folinic acid | 02 | N | 310000475 | DOXORUBICIN |
| 310010789 | 310005414 | null | 72 | null | 2018-09-18 | 2018-09-18 | Cyclophosphamide Fludarabine (Oral) | 02 | N | 310000647 | OXALIPLATIN + MDG |
| 310010790 | 310005424 | null | 54.1 | Palliative (P) | 2017-11-25 | 2017-12-10 | TRASTUZUMAB | 02 | null | 310001118 | CISPLATIN + FLUOROURACIL + RT |
| 310010791 | 310009971 | null | null | Adjuvant (A) | 2016-01-21 | 2016-01-28 | IPILIMUMAB + NIVOLUMAB | N | N | 310001253 | DABRAFENIB |
| 310010792 | 310005429 | 1.59 | 110 | Palliative (P) | 2017-09-12 | 2017-09-28 | Cytarabine+Methotrexate Intrathecal | N | N | 310001330 | ALL INTENSIFICATION |
| 310010793 | 310005431 | 1.8 | null | Curative (C) | 2018-12-16 | 2018-12-28 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | 310001357 | SUNITINIB |
| 310010794 | 310005438 | 1.63 | null | Neo-adjuvant (N) | 2017-10-14 | 2017-10-14 | MELPHALAN | 2 | null | 310001682 | BCG |
| 310010795 | 310005441 | 1.46 | null | Palliative (P) | 2013-12-07 | 2013-12-21 | Alemtuzumab (Subcutaneous) | Y | null | 310001938 | BCG |
| 310010796 | 310005446 | 1.73 | 65.05 | Palliative (P) | 2017-06-28 | 2017-11-16 | Bevacizumab + FLUOROURACIL + IRINOTECAN | N | N | 310002273 | FLUOROURACIL + MITOMYCIN + RT |
| 310010797 | 310005446 | 1.48 | null | Palliative (P) | 2015-07-18 | 2015-07-18 | Cytarabine intrathecal | N | N | 310002273 | DACARBAZINE |
| 310010798 | 310005450 | null | 63 | Palliative (P) | 2015-12-19 | 2015-12-19 | PERTUZUMAB + TRASTUZUMAB | 02 | N | 310002562 | EOX |
| 310010799 | 310005453 | null | 47.1 | Neo-adjuvant (N) | 2014-07-03 | 2014-11-05 | Hydroxycarbamide | N | N | 310002632 | FEC |
| 310010800 | 310009978 | 1.76 | 71 | Palliative (P) | null | 2018-03-14 | Cyclophosphamide Fludarabine (Oral) | 02 | N | 310003095 | VINBLASTINE |
| 310010801 | 310005458 | 1.76 | 50.5 | Adjuvant (A) | 2017-12-24 | 2017-12-31 | Dacarbazine | N | N | 310003191 | IGEV R |
| 310010802 | 310005462 | 1.64 | 71.5 | Palliative (P) | 2019-05-29 | 2019-05-30 | Doxorubicin + Ifosfamide | 2 | N | 310003401 | CYTARABINE HIGH DOSE |
| 310010803 | 310005463 | 1.63 | null | Palliative (P) | 2018-09-12 | 2019-03-01 | EOX | N | N | 310003601 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE |
| 310010804 | 310005465 | 1.55 | 74.1 | Palliative (P) | 2016-01-21 | 2016-02-06 | Capecitabine | 2 | N | 310003649 | OCTOPUS TRIAL |
| 310010805 | 310005466 | 0 | 66.6 | Adjuvant (A) | 2018-06-28 | 2018-07-05 | Alemtuzumab | N | N | 310003672 | CVP R + ETOPOSIDE |
| 310010806 | 310005471 | 1.75 | null | Adjuvant (A) | 2017-03-26 | 2017-04-23 | Cetuximab 7 day (>Cycle 2) | N | N | 310003732 | BEVACIZUMAB + IRINOTECAN + MDG |
| 310010807 | 310005475 | 1.62 | 53.6 | Palliative (P) | 2017-12-23 | 2018-09-15 | Trabectedin | N | null | 310003761 | CISPLATIN + FLUOROURACIL |
| 310010808 | 310005479 | 1.52 | null | Palliative (P) | 2015-04-07 | 2015-07-23 | TOPOTECAN | N | N | 310003808 | ICON TRIAL |
| 310010809 | 310009987 | 1.68 | null | Palliative (P) | 2014-06-14 | 2014-07-29 | Triple Intrathecal | 2 | null | 310004066 | EOX |
| 310010810 | 310005485 | null | 115.9 | Disease modification (D) | 2016-12-16 | 2018-05-21 | CODOX M | 2 | N | 310005210 | DHAP |
| 310010811 | 310005487 | 1.58 | 73.6 | Palliative (P) | 2014-04-12 | 2014-05-27 | Trabectedin | 02 | N | 310005975 | CISPLATIN + LIPOSOMAL DOXORUBICIN |
| 310010812 | 310005490 | 1.8 | 100.65 | Curative (C) | null | 2015-06-28 | Alemtuz+Fludara+Melphalan RIC MUD | N | Y | 310005975 | HYDROXYCARBAMIDE |
| 310010813 | 310005493 | 0 | null | Neo-adjuvant (N) | 2016-05-10 | 2016-06-21 | DABRAFENIB | null | null | 310006698 | CHOEP |
| 310010814 | 310008429 | 1.81 | 87.7 | Palliative (P) | 2016-01-05 | 2016-01-19 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | 310007286 | VINBLASTINE |
| 310010815 | 310005501 | 1.8 | null | Palliative (P) | 2016-08-04 | 2018-07-04 | CARBOPLATIN + RT | N | N | 310007470 | GEMCITABINE + OXALIPLATIN |
| 310010816 | 310010851 | 1.62 | null | Adjuvant (A) | 2014-01-24 | 2014-01-28 | DA-EPOCH-R | 02 | null | 310007558 | DOXORUBICIN |
| 310010817 | 310005505 | 1.2 | null | Palliative (P) | 2016-08-15 | 2016-12-04 | CETUXIMAB + RT | N | N | 310007855 | VEMURAFENIB |
| 310010818 | 310009999 | 1.53 | 69.8 | Curative (C) | 2018-12-23 | 2018-12-29 | MTX HD + PROCARBAZINE + VINCRISTINE | N | null | 310009263 | OXALIPLATIN + MDG |
| 310010819 | 310005514 | 1.76 | 132.4 | Palliative (P) | 2017-05-07 | 2017-10-09 | CISPLATIN + GEMCITABINE + RITUXIMAB | 2 | N | 310010718 | TEMOZOLOMIDE |
| 310010820 | 310010002 | 1.75 | 86.2 | Disease modification (D) | 2015-06-03 | 2015-10-07 | ICE + GCSF | 02 | N | 310011142 | CETUXIMAB + RT |
| 310010821 | 310005519 | 1.83 | 58.9 | Disease modification (D) | 2016-01-02 | 2016-01-30 | PMitCEBO | Y | N | 310011231 | CYTARABINE INTRATHECAL |
| 310010822 | 310008443 | null | 110 | Palliative (P) | 2017-03-16 | 2017-03-20 | Cyclophosphamide + Etoposide (iv) | 02 | N | 310011253 | INTERFERON |
| 310010823 | 310005525 | 1.76 | 99.8 | null | 2019-09-23 | 2019-10-01 | NIVOLUMAB | N | null | 310012201 | TRABECTEDIN |
| 310010824 | 310005526 | 1.69 | null | null | null | 2017-03-06 | Sunitinib | 02 | null | 310012353 | TRIPLE INTRATHECAL |